GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 70 filers reported holding GLYCOMIMETICS INC in Q2 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,559,000 | -11.0% | 287,031 | 0.0% | 0.23% | -4.2% |
| Q4 2016 | $1,751,000 | -14.7% | 287,031 | 0.0% | 0.24% | +4.4% |
| Q3 2016 | $2,052,000 | -1.7% | 287,031 | 0.0% | 0.23% | -23.6% |
| Q2 2016 | $2,087,000 | +23.5% | 287,031 | +1.2% | 0.30% | +16.1% |
| Q1 2016 | $1,690,000 | +4.2% | 283,555 | 0.0% | 0.26% | +31.4% |
| Q4 2015 | $1,622,000 | -36.9% | 283,555 | -38.2% | 0.19% | -52.7% |
| Q3 2015 | $2,570,000 | -29.6% | 458,955 | 0.0% | 0.41% | -15.5% |
| Q2 2015 | $3,649,000 | -4.5% | 458,955 | 0.0% | 0.48% | -17.8% |
| Q1 2015 | $3,819,000 | +12.3% | 458,955 | -2.8% | 0.59% | +12.6% |
| Q4 2014 | $3,401,000 | +3.8% | 472,300 | 0.0% | 0.52% | -22.3% |
| Q3 2014 | $3,278,000 | -17.7% | 472,300 | 0.0% | 0.67% | -36.1% |
| Q2 2014 | $3,981,000 | -48.1% | 472,300 | +0.6% | 1.06% | -40.2% |
| Q1 2014 | $7,665,000 | – | 469,400 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $4,500,000 | 0.69% |
| Artal Group S.A. | 8,589,064 | $12,884 | 0.55% |
| NEA Management Company, LLC | 4,764,440 | $7,146,660 | 0.55% |
| BVF INC/IL | 9,544,262 | $14,316,393 | 0.39% |
| Intellectus Partners, LLC | 61,975 | $92,963 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 27,500 | $41,250 | 0.03% |
| Sargent Investment Group, LLC | 58,000 | $87,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 93,785 | $141 | 0.01% |
| AXA S.A. | 1,625,698 | $2,438,547 | 0.01% |
| XTX Topco Ltd | 32,722 | $49,083 | 0.01% |